Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that it has filed an investor presentation with the Securities and Exchange Commission (“SEC”) and posted the presentation under the “Investors” section of the Company’s website detailing its initial concerns about the sustainability of Valeant Pharmaceuticals International, Inc.’s (“Valeant”) business model.
Help employers find you! Check out all the jobs and post your resume.
